Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells
Parviz Kokhaei(Arak University of Medical Sciences), Håkan Mellstedt(Karolinska University Hospital), Anders Österborg(Karolinska University Hospital), Ali Rashidy‐Pour(Semnan University of Medical Sciences), Marzia Palma(Karolinska University Hospital), Lotta Hansson(Karolinska Institutet), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Fatemeh Pak(Karolinska Institutet), Fariba Mozaffari(Karolinska University Hospital), Ali Moshfegh(Karolinska University Hospital)
Cited by 6
Related Papers
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2010|587
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2022|453
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312